Patents Assigned to BETA CELL TECHNOLOGIES, PTY LTD
  • Cell population seeding in dermal matrices for endocrine disorder management
    Patent number: 10695379
    Abstract: A method of delivering a cell derived factors to a subject is described, which includes implanting a matrix material into an intracutaneous location in the subject that results in increased vascularisation and subsequently efficient delivery of the required cell derived factors to the subject. The implanted matrix material can be loaded in-situ or alternatively pre-loaded and inserted into the appropriate location depending on requirements.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: June 30, 2020
    Assignee: BETA CELL TECHNOLOGIES, PTY LTD
    Inventors: John Greenwood, Patrick Toby Hewlett Coates